Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-24 @ 1:00 PM
NCT ID:
NCT06831461
Eligibility Criteria:
Inclusion Criteria:
* Primary brain tumors
* Age at irradiation: 18 to 70 years
* Karnofsky Performance Status ≥ 60
* Diagnosis (histopathological/ radiological) of primary brain tumor with an expected survival of \>5 years (e.g., grade 2-3 diffuse glioma, low-grade glial/ glioneuronal tumors, ependymoma, meningioma, pituitary tumors, schwannoma, craniopharyngioma, etc.)
* Planned for focal cranial radiotherapy
* Informed consent taken
Exclusion Criteria:
* Re-irradiation
* Palliative radiotherapy
* Multifocal or multicentric disease
* Planned for whole brain irradiation or craniospinal irradiation
* Planned for hypo-fractionated or stereotactic radiotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT06831461
Study Brief:
Protocol Section:
NCT06831461